RxDoctor Payments Data

Audrea Merchant, MD

Psychiatry · Oak Ridge, TNNPI 1457457475

Payments from drug & device makers

$1,848in general payments, 2019–2025

Across 105 payments — averaging $17.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$369
  • Takeda Pharmaceuticals U.S.A., Inc.$202
  • Neurocrine Biosciences, Inc.$200
  • Alkermes, Inc.$191
  • Otsuka America Pharmaceutical, Inc.$149
  • Lundbeck LLC$102
  • plus $636 from 13 others

What the payments were for

  • Food & beverage$1,848100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,848 in reported general payments places this provider in the 75th percentile of 503 psychiatry providers in Tennessee.

See all psychiatry providers in Tennessee

Medicare billing

Part B allowed, 2024
$60,310
Medicare patients
65
Services billed
611

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
RexultiBrexpiprazole40$76,352
TrintellixVortioxetine Hydrobromide63$47,167
VraylarCariprazine Hcl37$43,108
Aprepitant11$38,017
OzempicSemaglutide35$35,205
LybalviOlanzapine/Samidorphan Malate14$21,305
VyvanseLisdexamfetamine Dimesylate19$7,711
Vilazodone Hcl80$6,102
Bupropion XlBupropion Hcl127$5,327
Duloxetine Hcl136$4,167
Oxcarbazepine18$3,521
Lamotrigine228$3,423
Venlafaxine Hcl ErVenlafaxine Hcl134$2,678
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine110$2,566
Quetiapine Fumarate110$2,390

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Otsuka America Pharmaceutical, Inc.Rexulti$149$76,35240 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix, Vyvanse$202$54,87882 claims
AbbVieVraylar$369$43,10837 claims
Alkermes, Inc.Lybalvi$191$21,30514 claims
Lilly USA, LLCOlanzapine$22$1,19965 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 503 psychiatry providers in Tennessee.

Other psychiatry in Oak Ridge

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →